Toxicokinetics of p-tert-octylphenol in female DA/Han rats after single i.v. and oral application. 1999

A Upmeier, and G H Degen, and U S Schuhmacher, and H Certa, and H M Bolt
Institut für Arbeitsphysiologie an der Universität Dortmund, Germany.

Female DA/Han rats were administered p-tert-octylphenol [OP; p-(1,1,3,3-tetramethylbutyl)-phenol], either intravenously (5 mg/kg body wt.) or orally by gavage (50 or 200 mg/kg body wt.). After i.v. administration the blood concentration-time curve of OP was fitted to a tri-exponential model, resulting in a final half-life (gamma-phase) of 36.1 h. This contrasts to much more rapid eliminations previously reported in male Wistar rats. The oral bioavailability of 50 mg/kg OP was 12.3% and of 200 mg/kg 8.4%. The higher dose (200 mg kg) was absorbed slower than the smaller dose, probably due to low solubility of OP in aqueous media. Maximal OP blood levels in female DA/Han rats receiving 50 and 200 mg OP/kg body wt, were 4.5 and 3 times higher than previously reported in male Wistar rats. The blood concentration-time curves after oral administration of OP to female DA/Han rats revealed pronounced interindividual differences, indicating extensive enterohepatic circulation of OP in this rat strain. In contrast to male Wistar rats, after application of high doses of OP to female DA/Han rats the compound was not completely eliminated within 48 h: under these conditions some bioaccumulation might therefore occur. The experimental toxicokinetics of OP appears as a relevant subject to be integrated into extrapolation of toxicological data, from in vitro to in vivo, and into systems of risk assessment of endocrine modulating activity which are currently being developed.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D004764 Enterohepatic Circulation Recycling through liver by excretion in bile, reabsorption from intestines (INTESTINAL REABSORPTION) into portal circulation, passage back into liver, and re-excretion in bile. Circulation, Enterohepatic,Entero-Hepatic Circulation,Circulation, Entero-Hepatic,Circulations, Entero-Hepatic,Circulations, Enterohepatic,Entero Hepatic Circulation,Entero-Hepatic Circulations,Enterohepatic Circulations
D005260 Female Females
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

A Upmeier, and G H Degen, and U S Schuhmacher, and H Certa, and H M Bolt
October 2006, Archives of toxicology,
A Upmeier, and G H Degen, and U S Schuhmacher, and H Certa, and H M Bolt
January 2009, Journal of toxicology and environmental health. Part A,
A Upmeier, and G H Degen, and U S Schuhmacher, and H Certa, and H M Bolt
January 1996, Archives of toxicology,
A Upmeier, and G H Degen, and U S Schuhmacher, and H Certa, and H M Bolt
January 2000, Reproductive toxicology (Elmsford, N.Y.),
A Upmeier, and G H Degen, and U S Schuhmacher, and H Certa, and H M Bolt
January 2010, Journal of toxicology and environmental health. Part A,
A Upmeier, and G H Degen, and U S Schuhmacher, and H Certa, and H M Bolt
July 2010, Journal of applied toxicology : JAT,
A Upmeier, and G H Degen, and U S Schuhmacher, and H Certa, and H M Bolt
June 2000, Toxicology and applied pharmacology,
A Upmeier, and G H Degen, and U S Schuhmacher, and H Certa, and H M Bolt
March 2005, Endocrine,
A Upmeier, and G H Degen, and U S Schuhmacher, and H Certa, and H M Bolt
December 2003, Biopharmaceutics & drug disposition,
A Upmeier, and G H Degen, and U S Schuhmacher, and H Certa, and H M Bolt
June 2011, Toxicology,
Copied contents to your clipboard!